Lower Respiratory Tract Infections
Cross-source consensus on Lower Respiratory Tract Infections from 1 sources and 4 claims.
1 sources · 4 claims
Other
Other
Highlighted claims
- The primary outcome is the presence or absence of parent-reported, health professional-confirmed unscheduled visits for lower respiratory tract infections over the first year corrected-age window. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol
- Healthcare contacts counted for the primary outcome include GP, emergency department, paediatric assessment unit and hospital admission contacts. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol
- A new lower respiratory tract infection episode requires an intervening well period of at least 72 hours. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol
- The trial defines a lower respiratory tract infection using fever or rhinitis plus at least one additional respiratory or feeding symptom. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol